(Q35759054)

10 August 2017

Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections (English)

1 reference

10 August 2017

1 reference

Chonghua Li

1

1 reference

10 August 2017

Xiaoli Du

series ordinal

2

1 reference

10 August 2017

Joseph L Kuti

series ordinal

3

1 reference

10 August 2017

David P Nicolau

series ordinal

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

16 February 2007

1 reference

Antimicrobial Agents and Chemotherapy

10 August 2017

1 reference

10 August 2017

51

1 reference

10 August 2017

1725-1730

1 reference

10 August 2017

5

1 reference

Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855547

Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855547

Pharmacodynamics of cefepime in patients with Gram-negative infections

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855547

Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855547

Meropenem: an updated review of its use in the management of intra-abdominal infections

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855547

In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855547

Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855547

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855547

Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855547

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855547

Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855547

Meropenem, a new carbapenem antibiotic.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855547

Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855547

Population pharmacokinetics and pharmacodynamics of meropenem in pediatric patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855547

Correlation of meropenem plasma levels with pharmacodynamic requirements in critically ill patients receiving continuous veno-venous hemofiltration

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855547

Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17307978

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prevention of resistance: a goal for dose selection for antimicrobial agents

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17307978

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The pharmacodynamics of beta-lactams

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17307978

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00294-06

1 reference

10 August 2017

1 reference

10 August 2017

1 reference